Breaking News
June 23, 2018 - When the Heart Stops, Drugs Often to Blame
June 23, 2018 - Scientists show that a key Parkinson’s biomarker can be identified in the retina
June 23, 2018 - Study finds factors underlying current rise in radicalization among European youth
June 23, 2018 - New study finds higher heart disease risk in bisexual men
June 23, 2018 - Coconut oil diet increases vitality, lifespan of fruit flies with peroxisomal disorder
June 23, 2018 - Jumping genes or transposons and their role in the genetic code
June 23, 2018 - The Current issue of “The view from here” is concerned with Therapeutics
June 23, 2018 - Abnormal lipid metabolism in fat cells predicts future weight gain and diabetes in women
June 23, 2018 - Alcohol problems linked to sex without condom use among black gay men
June 23, 2018 - DNA patterns in circulating blood cells can help identify spastic cerebral palsy
June 23, 2018 - Unsubstantiated health claims widespread within weight loss industry
June 23, 2018 - FDA grants marketing authorization for use of two catheter-based devices in hemodialysis patients
June 23, 2018 - An ingrown toenail not the same as a bypass
June 23, 2018 - Study suggests proteinuria lowering as important target in managing pediatric CKD
June 23, 2018 - FDA Alert: Kratom (mitragyna speciosa) powder products by Gaia Ethnobotanical: Recall
June 23, 2018 - Study highlights inadequate effort of health care insurers to combat opioid epidemic
June 23, 2018 - CDC chief asks for, and gets, cut to his record $375K pay
June 22, 2018 - Novel cellular pathway may clarify how arterial inflammation develops into atherosclerosis
June 22, 2018 - Pioneering exercise program improves physical, mental health of elderly people living in care homes
June 22, 2018 - Rutgers Cancer Institute educates childhood cancer survivors about late effects of treatment
June 22, 2018 - Study tests accuracy of device designed to detect heart dysfunction in childhood cancer survivors
June 22, 2018 - Study links annual haze with increased hospitalizations for respiratory problems
June 22, 2018 - Robotic surgery appears to be as effective as open surgery in treating bladder cancer
June 22, 2018 - Many Drugs Made Available Via FDA Expanded Access Programs
June 22, 2018 - Normal eye dominance is not necessary for restoring visual acuity in amblyopia
June 22, 2018 - Parent-Child Interaction Therapy can reduce depression rates in children
June 22, 2018 - Study provides insights into how components of different cells in the brain are altered
June 22, 2018 - Research does not confirm antidiabetic action of natural fatty acid derivatives
June 22, 2018 - Oxidative stress can be used against tumors to treat cancer
June 22, 2018 - Simple, cost-effective test may help improve early diagnosis of mild cognitive impairment
June 22, 2018 - New guide published to help battle fatal disease caused by kissing bugs
June 22, 2018 - Stigma Adds to Burden of Type 1 Diabetes
June 22, 2018 - In retinoblastoma survivors, oculo-visual issues tied to QoL
June 22, 2018 - Most adults with allergies do not use prescribed epinephrine even in emergency situations
June 22, 2018 - Study provides clues to how cancer cells develop resistance to chemotherapies
June 22, 2018 - New consensus paper serves as basis for uniform medical management of DSD
June 22, 2018 - Researchers work to identify areas of the brain that help us wake up
June 22, 2018 - Alcohol hangovers more significant and costly than people realize, shows research
June 22, 2018 - Targeting cells involved in blood vessel formation could hinder brain tumor growth
June 22, 2018 - Young cancer survivors need more support as they feel dissatisfied with their sexuality
June 22, 2018 - Unusual cell-to-cell communication in glioblastoma promotes aggressiveness and therapy resistance
June 22, 2018 - Turning A Phage – Drug Discovery Today
June 22, 2018 - World-first study links birth interventions and long-term childhood illness
June 22, 2018 - Improving the quality of biomedical research samples
June 22, 2018 - Researchers identify cerebral palsy using AI and DNA sequencing
June 22, 2018 - Administering nitric oxide gas after heart surgery may decrease risk of kidney problems
June 22, 2018 - Measuring levels of ethyl sulphate in hair can help assess alcohol consumption
June 22, 2018 - Researchers develop robot bloodhound that can rapidly detect odors on the ground
June 22, 2018 - AAA doses first patients in two clinical studies with PSMA-R2 for prostate cancer
June 22, 2018 - LSTM led consortium receives grant to investigate how human behavior impacts AMR
June 22, 2018 - Researchers discover drug compound that inhibits movement of cancer cells
June 22, 2018 - Normalization of ‘plus-size’ body shapes may prevent recognition of health risks of obesity
June 22, 2018 - UC San Diego launches new bacteriophage therapy center
June 22, 2018 - New review outlines current state of sex-sensitive issues linked to heart failure drugs
June 22, 2018 - Pelvic pain a major issue for women nearing mid-life, research reveals
June 22, 2018 - Researchers develop reliable DNA barcodes for biomedical research
June 22, 2018 - New risk-prediction model may help identify diabetic patients at high risk of pancreatic cancer
June 22, 2018 - Study reveals how mTORC1-driven changes in crowding could influence major diseases
June 22, 2018 - Researchers uncover new therapeutic opportunity in the treatment of malignant melanoma
June 22, 2018 - UC Riverside researcher receives grants to advance cancer, ALS research
June 22, 2018 - Radiation therapy alone may be enough to treat older, sicker patients with anal cancers
June 22, 2018 - Technical report describes how to make accurate particle size measurements on carbon black samples
June 22, 2018 - Nocdurna (desmopressin acetate) Approved by FDA as First Sublingual Tablet to Treat Nocturia due to Nocturnal Polyuria
June 22, 2018 - Neuroscientists locate neurons in the brain that respond when a visual target is found
June 22, 2018 - First human Keystone virus infection reported
June 22, 2018 - New study reveals how ‘good’ bacteria help in regulating our metabolism
June 22, 2018 - Osteopathic manual therapy affecting the diaphragm improves chronic low back pain
June 22, 2018 - Researchers create revolutionary model to study pulmonary diseases
June 22, 2018 - Diagnosing Heart Disease Using AI
June 22, 2018 - Increasing biodefense risks posed by synthetic biology
June 22, 2018 - Many Women Report Vasomotor Symptoms in Their 60s
June 22, 2018 - Rare mutation of gene carried by Quebec family gives insight into how the brain is wired
June 22, 2018 - Chemists find new way to make enzymes do a non-natural reaction
June 22, 2018 - Summer is good time to check for signs of skin cancer
June 22, 2018 - Innovative method can help identify patients with spastic cerebral palsy
June 22, 2018 - Exercise alters characteristics of blood to reduce inflammation in obese people
June 22, 2018 - Researchers examine complications across different types of breast reconstructive surgeries
June 22, 2018 - Rhesus macaque model could be useful to test therapies for congenital Zika virus syndrome
June 22, 2018 - AHA: New Insights Into Sickle Cell and Stroke Risk
June 22, 2018 - Doctors prescribe opioids at high rates to those at increased overdose risk
Monitoring the Environment of Aseptic Processes

Monitoring the Environment of Aseptic Processes

image_pdfDownload PDFimage_print

An interview with Lisa G. Lawson, MS- Global Pharma GMP Advisor at Particle Measuring Systems.

Please define the meaning of “risk” from the perspective of environmental monitoring.

Risk assessment consists of the identification of hazards and the analysis and evaluation of risks associated with exposure to those hazards. The risk assessment of particle and microbiological samples should consider:

  • Highest risk of contamination of the product and its components (study of the airflows and exhaust grid)
  • Personnel operations
  • Material and personnel flows
  • Cleaning and sanitizing of environments and equipment

Credit: CoolaM/ Shutterstock.com

What are the stages of an aseptic process and which point is most vulnerable to contamination?

Two clean areas are of particular importance to sterile drug product quality: the critical area and the supporting clean areas associated with it.

Critical areas are where the product is most susceptible to contamination. Most commonly, this is during manipulation of sterile materials before and during filling and closing operations (eg, asceptic connections or the addition of sterile ingredients).

Here, a sterilized drug product becomes exposed to the environment and presents the opportunity for contamination – if this occurs, the product will no longer be sterilized when it reaches the sterile container. Therefore, we take extra care in ensuring the critical area is especially designed to ensure product sterility.

Of course, it is important to maintain product sterility by controlling the environment that aseptic processes take place, at a suitable quality. However, it’s not often considered that an aspect of environmental quality is the particle content of the air.

Particles can not only enter and contaminate a product extraneously, but can also contaminate a previously sterile drug product by acting as a vehicle for microbial contamination. Therefore, the environment of which aseptic processes take place should contain suitably designed air handling systems to reduce the particle content within a critical area.

Please outline the FMEA method for microbial monitoring. How does it identify and evaluate risk?

Quality Risk Management (QRM) activities are performed using systematic processes designed to coordinate, facilitate and improve science-based decision-making with respect to risk.

The analysis of the risk assessment is carried out using the FMEA method – the typical mathematical relationship that links the “Risk” RPI (Risk Priority Index) with the “Probability of contamination”, the “severity” of the expected damage, and the “Detectability” of the damage, summarized as: RPI = P1 x P2 x S x D.

  • P1 = The estimate of the probability of environmental contamination
  • P2 = The estimate of the probability of product contamination
  • S = Severity which defines the importance of danger on the basis of its consequences
  • D = The ability to detect any particles present in the environment through the use of different monitoring methods

How are levels of risk measured and what are the criteria for these?

The following is a typical matrix used to evaluate risk:

Therefore, the risk for controlled environments is defined as:

Following this analysis, you proceed to the next step which involves risk control. Risk control is a decision-making activity designed to reduce or accept risks of the existing microbiological/particle control.

The purpose of risk control is to reduce the risk to an acceptable level. Risk reduction includes all the actions to be taken to reduce the probability of contamination value or increase detectability value by employing specific methods of sampling.

What service can Particle Measuring Systems provide for sterility assurance?

Particle Measuring Systems provide our customers with the tools to ensure sterility of their products through comprehensive analysis and robust final documentation. We work closely with pharmaceutical companies to promote sterility education and successful procedure implementation.

We provide support on sterility assurance deviations, pharmaceutical process design evaluation and risk analysis, US and international regulatory audit support, and quality crisis management (warning letter and 483 observation response support).

If a risk is identified, how can the environment be altered to eliminate it? How easy is it to do this?

The purpose of risk control is to reduce the risk to an acceptable level.  Risk reduction includes all the actions to be taken to reduce the probability of contamination value or increase detectability value by employing specific methods of sampling.  These sampling methods may include: volumetric air sampling, settle plates, surface sampling and total particle air sampling

Do Particle Measuring Systems offer any support to help customers change their production process to eliminate any risks identified by using the service?

We offer support in many areas including but not limited to:

Training and certification in:

  1. Fundamentals of Microbiology
  2. Personnel Hygiene GMP practices
  3. Contamination Control
  4. Cleanroom qualification training
  5. Cleaning and Sanitization GMP practices
  6. Alternative Microbiological Methods training
  7. Risk Assessment use in contamination control
  8. Media Fill Requirements training
  9. FDA and EU guideline interpretation training
  10. Regulatory Update training
  11. Any other training topic that can customized to meet customer needs

Sterility Assurance issues handling including:

  1. Development of a Corporate Sterility Assurance program
  2. Training, development or qualification for sterilization and/or depyrogenation
  3. Aseptic Process Management and/or facility design projects which may include:
  • Review of production deviations, non-conformities or other investigations
  • Validation of microbial sampling systems and isolators for sterility testing

Inspection Support and Management including:

  1. Resolution of FDA 483, EMA or local authority compliance deviations
  2. On-site support during regulatory inspections

Quality By Design (QbD)and Process Analytical Technology (PAT) support

  1. Providing advice on how QbD/PAT may be incorporated in the business system
  2. Applying comparability protocols and other regulatory strategies for deployment

Process and Methods Evaluation and/or Risk Assessment including:

  1. Performance of formal risk analysis using Failure Modes and Effects Analysis (FMEA), Hazard Analysis (HACCP) or other Risk Analysis Tool
  2. Evaluation of laboratories, production and quality operations
  3. Development of programs or procedures
  4. Review of data trends and recommendation of alert and action levels

Pharmaceutical Microbiology Support including:

  1. Environmental Monitoring evaluation and development
  2. Evaluation and development of protocols and cleaning procedures
  3. Evaluation and development of procedures, policies and standards for media fill
  4. Microbiological Data Deviations (MDD) and analysis of Out-of-Specification (OOS)
  • Program Development and review of microbiological data deviations and OOS
  • Implementation of corrective action plans for reducing and/or eliminating MDD or OOS

Production and Quality Assurance Support including:

  1. Process Optimization, or project management assistance
  2. Comparability Protocols for process/analytical changes
  3. Cleaning and sanitization process analysis including practices, procedures and rationales/rotations
  4. Development of Quality Management System (QMS)
  5. Evaluation of systems based inspection compliance programs
  6. Support implementation of quality problem solving tools
  7. Assist in investigation resolution, reduction and root cause analysis

Quality Control Support including:

1.Laboratory Management

  • Optimization of laboratory policies, procedures, equipment and methods
  • Sterility test analysis and evaluation of positive sterility failure tests

2.Development of rapid methods for sterility testing

How often are sterility assurance methods reviewed or improved?

Once risk control measures have been identified, it is important to ensure all stakeholders are aware of the risks identified and are in alignment with the mitigation measures employed to reduce risk. Therefore, the last steps in the QRM process are risk communication and periodic risk review.

Risk communication is the sharing of information about risk and risk management between decision makers and others. Parties can communicate at any stage of the risk management process. The output/result of the quality risk management process should be appropriately communicated and documented.

Appropriate systems should be in place to ensure that the output of the QRM process is periodically monitored and reviewed, as appropriate, to assess new information that may impact the original QRM decision. Examples include changes to control systems, equipment and processes, suppliers or contractors and organizational restructuring.

What does the future hold for the development of environmental risk assessment? Will processes become completely automated?

The future for environmental risk assessment is to automate processes as much as possible to further reduce the risk of personnel contamination, as human interventions pose the greatest particulate and microbiological contamination risk to the product.

Where can readers find more information?

Please find more information on our Advisory services at the following link: https://www.pmeasuring.com/en/service-and-support/consultancy-training

To view our full line of innovative environmental monitoring products, go to: https://www.pmeasuring.com

About Lisa Lawson

Lisa G. Lawson has over 25 years’ experience in supporting large and small pharmaceutical companies in contamination control, including cleaning and disinfection strategies, aseptic manufacturing and use of risk-based approaches to microbiological quality challenges.

Lisa spent 16 years working for Amgen in microbial and mammalian cell culture manufacturing support and helped gain commercial FDA and international regulatory approval of the EPO/NESP manufacturing facility in Longmont, CO.

 

Tagged with:

About author

Related Articles